Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.

Excerpt from NPR. Original publication ↗

Source: NPR

At a glance

Topic
World
Country
🇺🇸 US
Publisher language
EN
Added to Allnira